פלודרה אורל - Fludara oral: הבדלים בין גרסאות

Fludara oral is indicated for the treatment of patients with B-cell chronic lymphocytic leukaemia (CLL) with sufficient bone marrow reserve and who have not responded to or whose disease has progressed during or after treatment with at least one standard alkylating-agent containing regimen. First line treatment with Fludara oral should only be initiated in patients with advanced disease, Rai stages III/IV (Binet stage C) or Rai stages I/II (Binet stage A/B) where the patient has disease related symptoms or evidence of progressive disease.